Clinical trial Recruiting at 1 site Interventional Ages 10 to 17

VR-based aerobic exercise versus treadmill exercise for kids with asthma

Official title: Comparison of Treadmill and Virtual Reality-Based Aerobic Exercise Programs in Children With Asthma

Run by Bezmialem Vakif University · NCT07610447 · Data updated 2026-11-12

A 8-week randomized study will compare virtual reality–based aerobic exercise to treadmill exercise in children aged 10–17 with asthma to see which improves how far they can walk in 6 minutes and other health outcomes.

Quick facts

Study typeInterventional
Ages10 Years to 17 Years
SexAll
Enrollment30 (estimated)
SponsorBezmialem Vakif University
Academic / other
Locations1 site (Istanbul, Eyupsultan)
StatusRecruiting
StartedMay 25, 2026
Main results expectedMay 10, 2027
Study endsMay 10, 2027
Registry record updatedJuly 21, 2026
Trial IDNCT07610447 on ClinicalTrials.gov

Is this trial a fit for you?

Likely a good fit

Children and adolescents aged 10–17 with physician-diagnosed asthma who are stable on treatment and able to participate in aerobic exercise.

Probably not a fit

Patients with contraindications to VR use or those unable to participate in the exercise program may not benefit.

A plain-English reading of the study's rules. Only the study team can confirm whether you qualify.

What this trial studies

This randomized, controlled study enrolls children and adolescents with physician-diagnosed asthma who will be assigned to either a virtual reality–based aerobic program or a standard treadmill-based program. Both groups receive supervised 40-minute sessions twice per week for eight weeks and begin with asthma education. Primary outcome is the change in the 6-Minute Walk Test; secondary outcomes include pulmonary function, respiratory muscle strength, asthma control, quality of life, and exercise adherence. The goal is to determine if gamified VR exercise can be as effective as conventional treadmill exercise while potentially improving motivation and adherence. The study acknowledges that regular aerobic activity is beneficial in asthma management but is often limited by symptoms and motivation, and it investigates whether VR could enhance participation.

Why it matters

Potential benefit: If successful, VR-based exercise could provide a more engaging option that improves physical capacity and asthma-related quality of life for pediatric patients.

How similar studies have gone: Limited evidence exists directly comparing VR-based aerobic exercise to conventional exercise in pediatric asthma, making this a relatively novel investigation with potential for meaningful insights.

Who can join: the full rules

Show full inclusion / exclusion criteria
Inclusion Criteria:

* Children and adolescents aged between 10 and 17 years
* Physician-diagnosed asthma according to Global Initiative for Asthma (GINA) criteria
* Stable medical treatment for asthma
* Ability to participate in an aerobic exercise program
* Willingness of the participant and parent/legal guardian to provide informed consent

Exclusion Criteria:

* Presence of orthopedic, neurological, cardiovascular, or systemic conditions limiting participation in exercise
* Contraindications to virtual reality use (e.g., epilepsy, photosensitivity)
* Participation in a structured exercise program within the previous month
* Asthma exacerbation within the previous month
* Obesity diagnosis

Where it's running

  • Bezmialem Vakif University
    Istanbul, Eyupsultan, Turkey (Türkiye)
    Recruiting

Study contacts

Similar studies

Other studies for the same condition or treatment. Recruiting studies are listed first.

How to take part

  1. Review the eligibility criteria above with your treating physician.
  2. Check the official listing on ClinicalTrials.gov for the latest contact details and recruitment status.
  3. Contact the study coordinator or principal investigator to ask for pre-screening. Pre-screening is free and never obligates you to enroll.
Last reviewed 2026-11-14 by the Find a Trial editorial team. Information on this page is for educational purposes and is not medical advice. Always consult qualified healthcare professionals about clinical trial participation.